AI & Machine Learning Startups

BindiMaps develops web-based and mobile indoor navigation solutions that help visitors plan routes through buildings and spaces with accessibility features for people with disabilities. The platform serves airports, shopping centers, venues, and other facilities to improve wayfinding and accessibility.

1 investor

Binoocle provides an AI-powered platform for construction sites that combines edge computing and cloud-based management to monitor workplace safety, reduce operational costs, and improve project efficiency. The solution delivers real-time event tracking, incident management, and document synthesis for construction businesses.

1 investor

Binsr is an AI-powered platform for home inspection companies that combines data migration, CRM, workflow automations, and AI-assisted report generation in a single system. It serves residential real estate inspectors and agents with features for client management, inspection documentation, and automated communications.

1 investor

Bioarchitech develops oncolytic virus therapies and RNA-based immunotherapy candidates for cancer treatment. The company combines expertise in viral engineering, immunology, and preclinical development to advance novel therapeutic platforms.

1 investor

Biobase builds data infrastructure to make clinical data accessible across the healthcare value chain, positioning itself as the "rails" for precision medicine rather than a data marketplace. It serves participants in the healthcare and life sciences sector by connecting data generated during care with downstream medicine development.

1 investor

A medical device company developing a non-invasive endoscopic capsule system for gastrointestinal imaging and diagnosis that patients can use at home while physicians monitor results remotely. The company serves gastroenterologists and patients requiring GI tract assessment.

1 investor

Biocartesian provides optical pooled screening services for functional genomics research. The company uses its proprietary ARADIA technology to link microscopy-based cellular phenotypes with genetic perturbations, enabling researchers to conduct large-scale CRISPR screens and other genomic studies with visual, spatial, and live-cell readouts.

1 investor

BioCorteX builds a biology-based knowledge graph of microbiome samples (Carbon Knowledge) and a foundational emulator (Carbon Mirror) that models interactions between bacteria, the human immune system, diseases, and drugs to generate insights for drug discovery and development. Its products serve the pharmaceutical and therapeutics industry.

1 investor

Biodiversity Intelligence measures and monitors biodiversity by combining eDNA sampling of soil and water, satellite and SAR remote sensing, climate data, and deep learning to produce standardized nature indices and indicators. It targets nature-market and land-use project operators, supporting nature disclosure, certification, and nature-based solutions through an interactive monitoring dashboard.

1 investor

Bioelectronica develops hardware and software tools for accelerated antibody discovery using single-cell protein secretion sorting combined with AI-driven sequence analysis. The company serves research institutions and biotech firms in the life sciences industry.

1 investor

BioEsol provides industrial and commercial energy management software and Energy as a Service (EaaS) solutions, optimizing energy consumption and incorporating battery energy storage systems (BESS) for businesses seeking to reduce operational energy costs and carbon emissions.

1 investor

Biofourmis provides technology-enabled solutions and a platform for AI-driven in-home patient care, using wearable biosensors and remote monitoring to deliver and transition patients across levels of care. It serves healthcare providers and partners, aiming to reduce hospital readmissions and cost of care.

1 investor

Biolinco provides a platform for cell line development that uses DNA barcoding and multi-omic characterization to help biopharmaceutical companies evaluate and select optimal cell clones. The platform addresses limitations in traditional workflows that evaluate only a small number of clones.

1 investor

BioLM provides AI/ML solutions for protein and DNA analysis, serving researchers and scientists in the biotechnology and synthetic biology sectors with tailored models and APIs.

1 investor

Biomakers operates a precision oncology platform that combines genomic testing, clinical data, biobanking, and AI to support cancer care and drug and diagnostic development. It focuses on expanding access to cancer care across Latin America while generating clinical and biospecimen data.

1 investor

BioModAI provides an autonomous AI agent that designs molecular biology assays, primers, CRISPR guides, and DNA constructs for research and biotech teams. The agent runs real bioinformatics tools on actual genomic data and delivers publication-ready reports with full audit trails, typically within hours.

1 investor

Bionamic provides a spreadsheet-based platform for annotating and profiling antibody and molecule developability, turning raw sequences into workbook records with features like numbering, PTM motifs, CDR ranges, and developability predictions (immunogenicity, solubility, aggregation propensity). It serves biotech and drug discovery teams working on molecule profiling and decision-making.

1 investor

BIonline offers an artificial intelligence platform for sales and marketing optimization, with prediction models for cross-selling, personalized recommendations, upselling, churn prevention, and next best action. Its web application is designed for business users and integrates with existing CRM and marketing automation systems.

1 investor

Bionomous develops automated laboratory systems that screen, sort, and plate small biological entities (300 μm–2 mm) such as fish eggs and larvae, plant seeds, hydrogel beads, and organoids, using high-resolution imaging and AI classification. Its EggSorter and Sortivo platforms serve academic research labs, aquaculture, and 3D cell culture workflows in the life sciences.

1 investor

BioPhy builds a suite of modular AI tools for pharmaceutical companies, automating quality, compliance, manufacturing, and supply-chain tasks such as SOP–regulation gap analysis, document consolidation, and IQ/OQ/PQ validation. Its platform targets pharma quality operations, manufacturing, and validation teams to reduce manual documentation and review work.

1 investor

BioSeek builds an AI platform for drug discovery that unifies fragmented biological sources—literature, patents, clinical, and chemistry data—into a connected knowledge graph, with specialist agents that reason across it from disease biology to safety-screened molecules. The software is deployed inside a customer's own infrastructure so proprietary data and tools join the private graph without leaving their environment, targeting enterprise pharma and biotech research teams.

1 investor

Biosortia develops an aquatic natural products drug discovery platform, leveraging marine organisms to identify pharmaceutical compounds for various therapeutic areas.

1 investor

Biospectal develops OptiBP, a smartphone app that measures and tracks blood pressure using a fingertip on the phone's camera, allowing users to record BP history and share it with doctors. The app is CE-MDR EU Class IIa certified and targets people managing hypertension and heart health.

1 investor

BioticsAI develops AI-powered computer vision solutions for fetal anatomy screening and maternal ultrasound diagnostics. The company serves healthcare providers and maternal-fetal medicine specialists seeking to standardize and improve the accuracy of prenatal ultrasound assessments.

1 investor